UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010536
Receipt number R000012320
Scientific Title Repetitive transcranial magnetic stimulation (rTMS) of primary motor cortex for intractable neuropathic pain: determination of the effect between 8 shaped coil and H-coil by consecutive rTMS and analysis of the mechanism
Date of disclosure of the study information 2013/04/19
Last modified on 2015/10/19 14:14:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Repetitive transcranial magnetic stimulation (rTMS) of primary motor cortex for intractable neuropathic pain: determination of the effect between 8 shaped coil and H-coil by consecutive rTMS and analysis of the mechanism

Acronym

Repetitive transcranial magnetic stimulation (rTMS) of primary motor cortex for intractable neuropathic pain: determination of the effect between 8 shaped coil and H-coil by consecutive rTMS and analysis of the mechanism

Scientific Title

Repetitive transcranial magnetic stimulation (rTMS) of primary motor cortex for intractable neuropathic pain: determination of the effect between 8 shaped coil and H-coil by consecutive rTMS and analysis of the mechanism

Scientific Title:Acronym

Repetitive transcranial magnetic stimulation (rTMS) of primary motor cortex for intractable neuropathic pain: determination of the effect between 8 shaped coil and H-coil by consecutive rTMS and analysis of the mechanism

Region

Japan


Condition

Condition

Intractable neuropathic pain

Classification by specialty

Neurology Neurosurgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysis of efficacy and safety of repetitive transcraanial magnetic stimulation, between 8 shaped coil and H-coil for intractable neuropathic pain

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

VAS (Visual analogue scale)

Key secondary outcomes

SF-MPQ 2(Short form of McGill pain questionnaire2)
patient global impression of change scale(PGIC)
Beck depression inventory(BDI)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Repetitive transcranial magnetic stimulation of H-coil

Interventions/Control_2

Repetitive transcranial magnetic stimulation of 8 shaped coil

Interventions/Control_3

Sham stimulation

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Intractable neuropathic pain for 6 months
(2)Patients who consented to keep drug and living conditions during the study
(3) No cognitive disorders, aphasia, psychiatric disorder, higher brain dysfunction
(4) the patients who can write questionare
(5) over 20 years old
(6) Those who give us informed consent to participate in the present study after detailed explanation of the study

Key exclusion criteria

(1) No implantation of metal in head, except in the mouth
(2) Those having heart pacemaker or drug infusion pomp
(3) Those having heart pacemaker or severe heart diseases
(4) Those having the deep brain stimulation or the spinal cord stimulation
(5)Major cerebral infarction, head traum, epilepsy, brain tumor
(6) Pregnant or intend to be pregnant
(7) the patients who are excluded by doctors

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Youichi Saitoh

Organization

Osaka university

Division name

Department of Neuromodulation and Neurosurgery,Office forUniversity-Industry Collaboration

Zip code


Address

2-1 Yamadaoka, Suita, Osaka

TEL

+81-6-6879-4138

Email

neurosaitoh@mbk.nifty.com


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Shimizu

Organization

Osaka university

Division name

Department of Neuromodulation and Neurosurgery,Office forUniversity-Industry Collaboration

Zip code


Address

2-1 Yamadaoka, Suita, Osaka

TEL

+81-6-6879-4138

Homepage URL


Email

Takeshi.Shimizu32@gmail.com


Sponsor or person

Institute

Osaka University, Department of Neuromodulation and Neurosurgery,Office forUniversity-Industry Collaboration

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 18 Day

Date of IRB


Anticipated trial start date

2013 Year 04 Month 19 Day

Last follow-up date

2015 Year 02 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 04 Month 18 Day

Last modified on

2015 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012320


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name